Page 1220 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 1220

1206     Index


                 Dimercaptosuccinic acid (DMSA),       adverse effects of, 658          carbonic anhydrase inhibitors, 259–261,
                        1030–1031                      anakinra, 657                          260t, 272t
                 Dimerization, 27                      canakinumab, 657                 clinical pharmacology of, 269–272
                 Dimethisterone, 728, 728t, 729f. See also   mechanism of action of, 657  edematous states, 269–270
                        Progestins                     rilonacept, 657–658                  edema, idiopathic, 270–271
                 Dimethylbenzene (xylene), 1010      leflunomide, 651                       general, 269–270
                 Dimethyl fumarate (DFMF), 989       methotrexate, 651–652                  heart failure, 270
                 Dimethylmercury, 1028               mycophenolate mofetil, 652             hepatic cirrhosis, 271
                 Dinoprostone (PGE 2 , PGF 2α ), 323  preparations available, 664t          kidney disease and renal failure,
                   abortion using, 334               rituximab, 652                           270–271
                   labor induction using, 333f, 335  sulfasalazine, 652–653               nonedematous states
                   structure of, 333f                tocilizumab, 653                       diabetes insipidus, 272
                 Dinutuximab, 992                    tofacitinib, 656–657                   hypercalcemia, 272
                 Dioxins, 1015                       tumor necrosis factor-α blocking agents,   hypertension, 271
                 Dipeptidyl peptidase-4 (DPP-4) inhibitors,   653–656                       nephrolithiasis, 271–272
                        762–763, 769t                  adalimumab, 652–654, 654f        combinations
                 Diphenhydramine                       adverse effects of, 655–656        loop and thiazide agents, 269
                   antiemetic properties of, 1106      certolizumab, 654f, 654–655        potassium-sparing with loop or
                   description of, 282f, 282–283, 283t,   etanercept, 654f, 655               thiazide diuretics, 269
                        296t. See also H 1 -receptor   golimumab, 654f, 655               potassium-sparing with proximal
                        antagonists                    infliximab, 654f, 655                  tubule diuretics, 269
                 Diphenoxylate, 568, 1100. See also Opioid   structures of, 654f        fundamentals of, 254
                        agonists                   Disinfectants and antiseptics, 897–901  heart failure treated with, 220, 224t, 227
                 Diphenylhydantoin, 418. See Phenytoin  alcohols, 898, 898t               acute, 224
                 Diphenylmethane derivative laxatives, 1099  aldehydes, 900               chronic, 221–222
                 Diphtheria vaccines                 chlorhexidine, 898t, 898–899         preparations available, 226t
                  diphtheria antitoxin, equine, 1180t  definitions of, 898t             hypertension treated with, 175,
                  diphtheria tetanus acellular pertussis   forms of, available, 902t          176–178, 179t, 191t
                        (DTaP), 1176t                fundamentals of, 897–898             mechanisms of action and hemody-
                  tetanus, diphtheria, pertussis (Tdap),   halogens                           namic effects of, 177
                        1178t                          chlorine, 899                      toxicity of, 178
                  tetanus-diphtheria (Td, DT), 1177t   iodine, 899                        use of, 177–178, 179t
                 Diphyllobothrium latum                iodophors, 899                   kidney injury from, acute, 254, 275
                  niclosamide for, 943                 phenolics, 899                   loop, 191t, 262f, 262t, 262–264, 273t,
                  praziquantel for, 944–945          heavy metals, 901                        274t
                 Dipyridamole, 206b, 621             peroxygen compounds, 900–901       osmotic, 267–268, 273t, 274t
                 Direct-acting antiviral agents (DAAs), 887  preservatives, 901         potassium-sparing, 191t, 265f, 265–267,
                 Direct factor Xa inhibitors, 616–617  quaternary ammonium compounds,         266t, 273t
                 Direct thrombin inhibitors                899                            drug interactions of, 1170t–1171t
                  oral, 618                          superoxidized water, 900             preparations available, 274t
                  parenteral, 617–618              Disinfection, 898t                     with proximal tubule diuretics, 269
                 Direct vasodilators, 176          Disopyramide, 239t, 240t, 240–241, 250t  preparations available, 274t
                 Discontinuation syndrome, 547     Disseminated intravascular coagulation   renal tubule transport and, 254–259.
                 Discovery, drug, 11–13, 12f               (DIC), 611                         See also Renal tubule transport
                 Disease-modifying antirheumatic drugs   Distal convoluted tubule (DCT), 255f,   mechanisms
                        (DMARDs), 649–659                  257, 257f                    sodium glucose cotransporter 2 (SGLT2)
                  abatacept, 649–650               Distribution, drug, 7. See also specific drugs  inhibitors, 261–262, 272t, 274t
                  azathioprine, 650                  drug interactions on, 1156         thiazide, 264–265. See also Thiazide
                  belimumab, 658                     models of, 45f                           diuretics
                  chloroquine and hydroxychloroquine,   Disulfiram                    Divalproex sodium, 426f, 426–427
                        650                          alcoholism treated with, 404, 406t, 407t  DNA guanine, 953
                  combination therapy, 658           drug interactions of, 1166t      DNA gyrase inhibitors, 837–840, 838f,
                  cyclophosphamide, 650–651        Diuresis, forced, 1040                     838t, 840t
                  cyclosporine, 651                Diuretics, 191t, 254–275, 273t–274t  Dobutamine, 141t, 149, 149f, 154t. See
                  fundamentals of, 649               antidiuretic hormone agonists, 268       also Sympathomimetics
                  glucocorticoid drugs, 658–659      antidiuretic hormone antagonists,   for cardiac stress test, 152
                  inflammation treated with, 643           268–269, 274t                heart failure treated with, 219, 224, 225t
                  interleukin-1 inhibitors           aquaretics, 267–268, 273t, 274t    structure of, 149f
   1215   1216   1217   1218   1219   1220   1221   1222   1223   1224   1225